Paul Horstmeier, Chief Operating Officer at Health Catalyst, Inc. (HCAT), sold 21,500 shares at $31.25 ($681K) on 2020-09-01, disclosed to the SEC on 2020-09-03.
Open-market sale of $681k HCAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.25 | 5,278 | $165K | 24.2% |
| 2 | $31.25 | 5,278 | $165K | 24.2% |
| 3 | $32.04 | 5,472 | $175K | 25.8% |
| 4 | $32.04 | 5,472 | $175K | 25.8% |
| Total | $31.65 avg | 21,500 | $681K | 100% |
| Filing → |
| HCAT | SELL | 2022-03-11 | $587K | — | Filing → |
| HCAT | SELL | 2022-02-09 | $626K | — | Filing → |
| HCAT | SELL | 2022-01-06 | $791K | — | Filing → |